Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of varicella vaccination in cartilage-hair hypoplasia
2015-000592-27Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Mar 2015
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of varicella virus vaccine live in chickenpox, sponsored by Helsinki University Hospital. Primary endpoint: Immune response to varicella vaccination. Started Mar 2015; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on 2015-000592-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000592-27.